Dr. Martens (LON:DOCS) Insider Ije Nwokori Sells 204,051 Shares of Stock

Dr. Martens plc (LON:DOCS) insider Ije Nwokori sold 204,051 shares of the business’s stock in a transaction on Wednesday, April 15th. The shares were sold at an average price of GBX 66, for a total transaction of £134,673.66.

Ije Nwokori also recently made the following trade(s):

• On Tuesday, April 14th, Ije Nwokori acquired 232 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 65 per share, for a total transaction of £150.80.
• On Wednesday, February 11th, Ije Nwokori acquired 219 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 69 per share, for a total transaction of £151.11.

Dr. Martens Stock Up 1.4%

Shares of LON DOCS opened at GBX 67.30 on Friday. The stock has a market capitalization of £650.61 million, a P/E ratio of 39.59, a P/E/G ratio of 6.40 and a beta of 0.24. The company has a 50-day moving average price of GBX 65.51 and a 200-day moving average price of GBX 75.70. Dr. Martens plc has a 1 year low of GBX 50.60 and a 1 year high of GBX 100.87. The company has a debt-to-equity ratio of 120.66, a current ratio of 2.18 and a quick ratio of 1.13.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Berenberg Bank reiterated a “buy” rating on shares of Dr. Martens in a research note on Tuesday, January 27th. Royal Bank Of Canada reissued a “sector perform” rating on shares of Dr. Martens in a research note on Tuesday, February 3rd. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of GBX 6,000.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.